NCT06625593 2026-05-29A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid TumorsBeOne MedicinesPhase 1 Recruiting168 enrolled